| 000 | 11114nam a22004813i 4500 | ||
|---|---|---|---|
| 001 | EBC5630287 | ||
| 003 | MiAaPQ | ||
| 005 | 20240724113510.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 240724s2019 xx o ||||0 eng d | ||
| 020 |
_a9781119226246 _q(electronic bk.) |
||
| 020 | _z9781119226222 | ||
| 035 | _a(MiAaPQ)EBC5630287 | ||
| 035 | _a(Au-PeEL)EBL5630287 | ||
| 035 | _a(OCoLC)1082215765 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aSF756.84 .C769 2019 | |
| 100 | 1 | _aCrowell-Davis, Sharon L. | |
| 245 | 1 | 0 | _aVeterinary Psychopharmacology. |
| 250 | _a2nd ed. | ||
| 264 | 1 |
_aNewark : _bJohn Wiley & Sons, Incorporated, _c2019. |
|
| 264 | 4 | _c©2019. | |
| 300 | _a1 online resource (333 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aIntro -- Title Page -- Copyright Page -- Contents -- Contributors -- Preface -- Acknowledgments -- Part I Principles of Veterinary Psychopharmacology -- Chapter 1 General Principles of Psychopharmacology -- Drug Action -- Dose Dependence of Drug Interaction with Receptors -- Structural Features of the Central Nervous System (CNS) and Neurotransmission -- Biogenic Amine Neurotransmitters and Affective Disorders -- References -- Chapter 2 Amino Acid Neurotransmitters: Glutamate, GABA, and the Pharmacology of Benzodiazepines -- Introduction -- Glutamatergic Synapses -- Pharmacology of Ketamine and Tiletamine -- GABAergic Synapses -- References -- Chapter 3 Biogenic Amine Neurotransmitters: Serotonin -- Introduction -- The Biogenic Amines -- Serotonin -- References -- Chapter 4 Biogenic Amine Transmitters: Acetylcholine, Norepinephrine, and Dopamine -- Acetylcholine -- Norepinephrine -- Dopamine -- References -- Chapter 5 Neuropeptides: Opioids and Oxytocin -- Introduction -- Endogenous Opioid Peptides -- Oxytocin -- References -- Part II Practice of Veterinary Psychopharmacology -- Chapter 6 Introduction to Clinical Psychopharmacology for Veterinary Medicine -- Introduction -- Prescribing in the United States: The Animal Medicinal Drug Use Clarification Act (AMDUCA 1994) -- Cost -- Drug Selection -- Medicating the Patient -- Competition Animals -- Taking the Behavioral History -- The Behavioral Exam -- Duration of Treatment -- Limitations -- References -- Chapter 7 Benzodiazepines -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Alprazolam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals. | |
| 505 | 8 | _aII. Chlordiazepoxide HC1 -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- III. Clonazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Drug Interactions -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- IV. Clorazepate Dipotassium -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Dependence -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- V. Diazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other -- Effects Documented in Nonhuman Animals -- VI. Flurazepam Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- VII. Lorazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Effects Documented in Nonhuman Animals -- VIII. Oxazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- IX. Triazolam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- Important Information for Owners of Pets Being Placed on Any Benzodiazepine -- References -- Chapter 8 Selective Serotonin Reuptake Inhibitors -- Action -- Overview of Indications. | |
| 505 | 8 | _aContraindications, Side Effects, and Adverse Events -- Adverse Drug Interactions -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Citalopram Hydrobromide -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- II. Fluoxetine Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation of Fluoxetine -- Other Information -- Effects Documented in Nonhuman Animals -- III. Fluvoxamine -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- IV. Paroxetine Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Discontinuation of Paroxetine -- Other Information -- Effects Documented in Nonhuman Animals -- V. Sertraline Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- VI. Escitalopram Oxalate -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- Important Information for Owners of Pets Being Placed on Any SSRI -- References -- Chapter 9 Miscellaneous Serotonergic Agents -- Introduction -- Azapirones -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Adverse Drug Interactions -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Buspirone -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals. | |
| 505 | 8 | _aSerotonin Antagonist/Reuptake Inhibitors (SARIs) -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Adverse Drug Interactions -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Trazodone Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- Note -- References -- Chapter 10 Anticonvulsants and Mood Stabilizers -- Action -- Overview of Indications -- Clinical Guidelines -- Specific Medications -- I. Carbamazepine -- Clinical Pharmacology -- Side Effects -- Effects in Non‐human Animals -- II. Gabapentin -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Other Information -- Effects Documented in Non‐human Animals -- Cattle -- III. Pregabalin -- Clinical Pharmacology -- Uses in Humans -- Side Effects -- Effects Documented in Nonhuman Animals -- References -- Chapter 11 Sympatholytic Agents -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Overdose -- Clinical Guidelines (Table 11.1) -- Specific Medications -- I. Clonidine -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- II. Detomidine -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- III. Dexmedetomidine -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Effects Documented in Nonhuman Animals -- IV. Propranolol -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Effects Documented in Nonhuman Animals -- References. | |
| 505 | 8 | _aChapter 12 N-Methyl-D-Aspartate (NMDA) Receptor Antagonists -- Action -- Overview of Indications -- Contraindications/Side Effects, and Adverse Events -- Clinical Guidelines -- Specific Medications -- I. Dextromethorphan -- Clinical Pharmacology -- Contraindications and Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- Horses -- II. Amantadine -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Overdose -- Effects Documented in Nonhuman Animals -- III. Memantine -- Clinical Pharmacology -- Use in Humans -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- IV. Huperzine A -- Clinical Pharmacology -- Use in Humans -- Overdose and Side Effects -- Effects Documented in Nonhuman Animals -- References -- Chapter 13 Monoamine Oxidase Inhibitors -- Action -- Overview of Indications -- Specific Medications -- I. Selegiline Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- References -- Chapter 14 Antipsychotics -- Introduction -- Action -- Overview of Indications -- General Pharmacokinetics -- Contraindications, Side Effects, and Adverse Events -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Acepromazine Maleate -- Clinical Pharmacology -- Indications -- Contraindications -- Side Effects -- Adverse Drug Interactions -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- II. Azaperone -- Clinical Pharmacology -- Indications -- Doses in Nonhuman Animals -- III. Chlorpromazine -- Clinical Pharmacology -- Uses in Humans -- Indications in Veterinary Medicine -- Contraindications -- Side Effects -- Effects Documented in Nonhuman Animals -- IV. Clozapine -- Clinical Pharmacology. | |
| 505 | 8 | _aUses in Humans. | |
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 650 | 0 | _aVeterinary psychopharmacology. | |
| 655 | 4 | _aElectronic books. | |
| 700 | 1 | _aMurray, Thomas F. | |
| 700 | 1 | _ade Souza Dantas, Leticia Mattos. | |
| 776 | 0 | 8 |
_iPrint version: _aCrowell-Davis, Sharon L. _tVeterinary Psychopharmacology _dNewark : John Wiley & Sons, Incorporated,c2019 _z9781119226222 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5630287 _zClick to View |
| 999 |
_c7520 _d7520 |
||